Dimerization With the Ghrelin Receptor: Implications for Weight Loss Drugs
Dec 03, 2015
Material below summarizes the article Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target, published on April 14, 2015, in eNeuro and authored by Martin Wellman and Alfonso Abizaid.
Ghrelin’s been a star among many researchers since its discovery in 1999. Its rise to fame is largely attributed to its role in feeding behavior, an area eagerly being examined as a result of our current obesity problems. Ghrelin, a peptide produced primarily by the stomach, increases food intake and preference for fatty foods, and protects fat stores.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
About the Contributor
Martin Wellman is the CEO and founder of Cryofrog Inc.
0 of 5 articles left
Login
or
Become a Member
to unlock content
